Acta Pharmaceutica Sinica B: 2023, vol: 13, issue: 11
- 1)- Yanyu Jiang, Shuaishuai Ni, Biying Xiao, Lijun Jia. Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4341-4372
Cited : 1Read More - 2)- Honggang Xiang, Mi Zhou, Yan Li, Lu Zhou, Renxiao Wang. Drug discovery by targeting the protein-protein interactions involved in autophagy. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4373-4390Cited : 4Read More
- 3)- Qiuyue Liu, Jiahui Zou, Zhongjian Chen, Wei He, Wei Wu. Current research trends of nanomedicines. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4391-4416Cited : 14Read More
- 4)- Yuyi Xu, Ming Zhao, Jinxue Cao, Ting Fang, Jian Zhang, Yanli Zhen, Fangling Wu, Xiaohui Yu, Yaming Liu, Ji Li, Dongkai Wang. Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4417-4441Cited : 4Read More
- 5)- Ying Tao, Xinmiao Lan, Yang Zhang, Chenxing Fu, Lu Liu, Feng Cao, Weisheng Guo. Biomimetic nanomedicines for precise atherosclerosis theranostics. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4442-4460Cited : 6Read More
- 6)- Yuhan Li, Xiangqing Ding, Xianxian Wu, Longfei Ding, Yuhui Yang, Xiaoliang Jiang, Xing Liu, Xu Zhang, Jianrong Su, Jianqing Xu, Zhiwei Yang. A non-human primate derived anti-P-selectin glycoprotein ligand-1 antibody curtails acute pancreatitis by alleviating the inflammatory responses. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4461-4476Cited : 1Read More
- 7)- Xiaowei Wang, Mengyan Wang, Meilian Cai, Rongguang Shao, Guimin Xia, Wuli Zhao. Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking POLG and TFAM-mediated mtDNA replication. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4477-4501Cited : 1Read More
- 8)- Saifei Lei, Alice Guo, Jie Lu, Qian Qi, Aaron S Devanathan, Junjie Zhu, Xiaochao Ma. Activation of PXR causes drug interactions with Paxlovid in transgenic mice. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4502-4510Cited : 0Read More
- 9)- Xiaoshuang Niu, Menghan Wu, Guodong Li, Xiuman Zhou, Wenpeng Cao, Wenjie Zhai, Aijun Wu, Xiaowen Zhou, Shengzhe Jin, Guanyu Chen, Yanying Li, Jiangfeng Du, Yahong Wu, Lu Qiu, Wenshan Zhao, Yanfeng Gao. Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4511-4522Cited : 1Read More
- 10)- Rebecca R Florke Gee, Andrew D Huber, Jing Wu, Richa Bajpai, Allister J Loughran, Shondra M Pruett-Miller, Taosheng Chen. The F-box-only protein 44 regulates pregnane X receptor protein level by ubiquitination and degradation. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4523-4534Cited : 1Read More
- 11)- Wanze Tang, Zhen Ding, Huanqing Gao, Qinnan Yan, Jingping Liu, Yingying Han, Xiaoting Hou, Zhengwei Liu, Litong Chen, Dazhi Yang, Guixing Ma, Huiling Cao. Targeting Kindlin-2 in adipocytes increases bone mass through inhibiting FAS/PPAR/FABP4 signaling in mice. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4535-4552Cited : 0Read More
- 12)- Zhongtang Li, Fan Fang, Yiyan Li, Xuehui Lv, Ruqiu Zheng, Peili Jiao, Yuxi Wang, Guiwang Zhu, Zefang Jin, Xiangqing Xu, Yinli Qiu, Guisen Zhang, Zhongjun Li, Zhenming Liu, Liangren Zhang. Carbazole and tetrahydro-carboline derivatives as dopamine D receptor antagonists with the multiple antipsychotic-like properties. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4553-4577Cited : 0Read More
- 13)- Xiaodong Zeng, Yuqin Liao, Xue Qiao, Ke Liang, Qiusi Luo, Mingbo Deng, Yishen Liu, Weijing Zhang, Xuechuan Hong, Yuling Xiao. Novel NIR-II fluorescent probes for biliary atresia imaging. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4578-4590Cited : 6Read More
- 14)- Chang Xiao, Yue Sun, Jialong Fan, William Nguyen, Simin Chen, Ying Long, Wei Chen, Aiguo Zhu, Bin Liu. Engineering cannabidiol synergistic carbon monoxide nanocomplexes to enhance cancer therapy excessive autophagy. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4591-4606Cited : 5Read More
- 15)- Yi Yang, Makhloufi Zoulikha, Qingqing Xiao, Feifei Huang, Qi Jiang, Xiaotong Li, Zhenfeng Wu, Wei He. Pulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4607-4620Cited : 1Read More
- 16)- Peiliang Shen, Yuanyuan Jia, Weijia Zhou, Weiwei Zheng, Yueyao Wu, Suchen Qu, Shiyu Du, Siliang Wang, Huilian Shi, Jia Sun, Xin Han. A biomimetic liver cancer on-a-chip reveals a critical role of LIPOCALIN-2 in promoting hepatocellular carcinoma progression. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4621-4637Cited : 2Read More
- 17)- Yuegui Chen, Qin Yan, Yunheng Ji, Xue Bai, Desen Li, Rongfang Mu, Kai Guo, Minjie Yang, Yang Tao, Jonathan Gershenzon, Yan Liu, Shenghong Li. Unraveling the serial glycosylation in the biosynthesis of steroidal saponins in the medicinal plant and their antifungal action. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4638-4654Cited : 2Read More
- 18)- Kaican Zong, Hui Zhou, Wen Li, E Jiang, Yi Liu, Shiying Li. Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4655-4660Cited : 3Read More
- 19)- Xuan Yang, Yalong Wang, Junke Zhao, Hehui Rong, Yujun Chen, Mengting Xiong, Xiaoxing Ye, Shihui Yu, Haiyan Hu. Erratum: Author correction to "Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy" [Acta Pharmaceutica Sinica B 12 (2022) 3934-3951]. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4661-4663Cited : 0Read More
- 20)- Canhao Wu, Qin Xu, Huiyuan Wang, Bin Tu, Jiaxin Zeng, Pengfei Zhao, Mingjie Shi, Hong Qiu, Yongzhuo Huang. Erratum: Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" [Acta Pharmaceutica Sinica B 12 (2022) 1523-1533]. Acta pharmaceutica Sinica. B. 2023, 13 (11): 4664-4666Cited : 0Read More
